THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
172,591,588
Share change
-16,298,665
Total reported value
$626,565,901
Put/Call ratio
148%
Price per share
$3.63
Number of holders
145
Value change
-$57,124,136
Number of buys
65
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q3 2019

As of 30 Sep 2019, THERAPEUTICSMD INC - COM (TXMD) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 172,591,588 shares. The largest 10 holders included JPMORGAN CHASE & CO, FMR LLC, BlackRock Inc., Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Rubric Capital Management LP, FRONTIER CAPITAL MANAGEMENT CO LLC, and STATE STREET CORP. This page lists 145 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.